Arteris Inc (AIP)vsZepp Health Corp (ZEPP)
AIP
Arteris Inc
$27.03
+5.38%
TECHNOLOGY · Cap: $1.25B
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 267% more annual revenue ($258.90M vs $70.58M). ZEPP leads profitability with a -15.5% profit margin vs -49.2%. ZEPP earns a higher WallStSmart Score of 41/100 (D).
AIP
Avoid27
out of 100
Grade: F
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-47.5%
Fair Value
$10.24
Current Price
$27.03
$16.79 premium
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 30.0% year-over-year
Conservative balance sheet, low leverage
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -1370.0% — below average capital efficiency
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : AIP
The strongest argument for AIP centers on Revenue Growth, Debt/Equity. Revenue growth of 30.0% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : AIP
The primary concerns for AIP are EPS Growth, Market Cap, Return on Equity.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
AIP profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (41/100 vs 27/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Arteris Inc
TECHNOLOGY · SEMICONDUCTORS · USA
Arteris Inc. (AIP) is a pioneering force in the semiconductor industry, focusing on interconnect IP solutions that are essential for advancing system-on-chip (SoC) architectures. With a commitment to innovation, Arteris enhances communication efficiency between chips, thereby improving overall data processing performance for a diverse range of clients in the fast-paced electronics market. The company's impressive product portfolio is strategically designed to address the growing complexity and performance demands of next-generation chip developments. Through strategic alliances, Arteris strengthens its market position, unlocking significant growth opportunities within the dynamic semiconductor landscape.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SEMICONDUCTORS Stocks
Want to dig deeper into these stocks?